Breaking News
Sort by:
Top Post
Amadeus Integrates IBM Digital Health Pass Into its Digital Health Verification Technology
IBM (NYSE: IBM) and Amadeus (MCE: AMS) today announced that they are working together to […]
Pfizer and BioNTech Announce Collaboration with Biovac to Manufacture and Distribute COVID-19 Vaccine Doses within Africa
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the signing of a letter of intent […]
Cityzenith and SafelyThrive Digital Twin Tech Partnership Delivers Major Solution to 'COVID Delta' Variant
As the world reels from the threat of COVID-19’s new and highly contagious Delta variant, […]
Government Launches Covid Pass Verifier App for Businesses
Trials of the COVID Pass in domestic settings supported the beginning of a summer of […]
RemedyBio Completes €10.5M Financing from European Innovation Council
RemedyBio, an immunology focused discovery and development company, today announces the final closing of an […]
Fully Vaccinated Critical Workers to be Able to Leave Self-isolation in Exceptional Circumstances
Railway signallers and air traffic controllers are among the critical workers who may in exceptional […]
TGen Looks Beyond COVID-19 as it Advances Pathogen Sequencing
Amidst the darkness of the pandemic, a shining light from the COVID-19 response is the […]
Almost 100% of People Have Antibodies After Second Vaccine
Imperial College London and Ipsos MORI have today published their latest antibody surveillance report showing, […]
New COVID-19 Saliva Test Makes Testing Far Easier for All Ages
UK company Intelligent Fingerprinting, manufacturers of the world’s first and only fingerprint sweat drug test, has […]
New Mega Laboratory Opens to Bolster Fight Against COVID-19
The UK’s first testing megalab – the Rosalind Franklin laboratory in Royal Leamington Spa has […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more